Skip to main content
logo
TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.50
+0.28 (0.38%)
At close: Mar 25, 2026

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Adjustments and Eliminations
---268.62M-274.72M-231.74M
Healthcare Business Group
186.34M195.63M581.66M221.48M212.63M
Healthcare Business Group Growth
-4.75%-66.37%162.62%4.16%-19.72%
Other Department
35.23M65.44M106.64M270.72M196.05M
Other Department Growth
-46.16%-38.64%-60.61%38.09%895.68%
Reinvestment Segment
1.12B814.45M747.28M--
Reinvestment Segment Growth
37.00%8.99%---
Cancer Drug Business Group
2.40B2.43B2.34B2.77B2.61B
Cancer Drug Business Group Growth
-1.21%3.78%-15.44%6.18%-13.82%
Export and OEM Group
936.49M796.70M653.68M--
Export and OEM Group Growth
17.55%21.88%---
Anti-infection medicine segment
1.22B1.20B899.62M1.14B989.45M
Anti-infection medicine segment Growth
1.32%33.77%-20.80%14.79%25.78%
Cardiovascular and Gastrointestinal Drugs Business Group
---413.48M447.86M
Cardiovascular and Gastrointestinal Drugs Business Group Growth
----7.68%-11.78%
Total
5.89B5.51B5.06B4.54B4.22B
Total Growth
7.05%8.77%11.60%7.43%-5.47%

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Taiwan
5.12B4.84B4.60B4.25B3.93B
Taiwan Growth
5.78%5.24%8.33%8.01%5.49%
America
381.29M265.71M59.43M--
America Growth
43.50%347.07%---
Other Countries
391.78M398.66M402.12M289.25M278.03M
Other Countries Growth
-1.73%-0.86%39.02%4.04%-13.19%
Europe
----12.20M
Europe Growth
-----97.09%
Total
5.89B5.51B5.06B4.54B4.22B
Total Growth
7.05%8.77%11.60%7.43%-5.47%
Source: S&P Global Market Intelligence.